Atrium Therapeutics, Inc. (RNA) - Latest Market Data

Price & Market Data

Price: $13.06

Daily Change: -$0.03 / 0.23%

Daily Range: $12.95 - $13.29

Market Cap: $223,399,712

Daily Volume: 170,807

Performance Metrics

1 Week: -1.13%

1 Month: -5.01%

3 Months: -10.22%

6 Months: -10.22%

1 Year: -10.22%

YTD: -10.22%

About Atrium Therapeutics, Inc. (RNA)

Financial summary for Atrium Therapeutics, Inc. (RNA). Price: 13.06, daily change: -$0.03 / 0.23%. Market cap: 223,399,712. Performance for all periods at a glance.

Company Details

Employees: 511

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.

Selected stocks

VIX Volatility ETF (VIXY)

Guardian Metal Resources PLC (GMTL)

Armada Acquisition Corp. III (AACI)

AGI Inc (AGBK)